Part II: It Takes a Team— Incorporating High-Sensitivity Troponin Into Clinical Care.

Slides:

Advertisements

Similar presentations

Local Opportunities (summary) Reduction in admissions to secondary care – proactive case management Whole systems planning and commissioning Recognising.

Advertisements

for the TRAPID-AMI Investigators

Copeptin and high sensitive Troponins Discussion of NEJM publications on sensitive Troponins BRAHMS GmbH, August 2010.

Journal Club Electronic Medical Record–Based Performance Improvement Project to Document and Reduce Excessive Cardiac Troponin Testing S.A. Love, Z.J.

The Health Roundtable Early detection of patient deteriopration Presenter: (delegate name) Innovation Poster Session HRT1215 – Innovation Awards Sydney.

Managing Advanced Illness to Advance Care Executive Briefing - AHA Annual Meeting Tuesday, April 30, :45am – 12:15pm © 2012 American Hospital Association.

Journal Club Optimizing Early Rule-Out Strategies for Acute Myocardial Infarction: Utility of 1-Hour Copeptin P. Hillinger, R. Twerenbold, C. Jaeger, K.

Identifying Heart Murmurs Through the Use of Artificial Neural Network Classifiers Aaron Aikin Supervisor: Roop Mahajan In collaboration.

Incidence of Undetectable, Measurable, and Increased Cardiac Troponin I Concentrations Above the 99th Percentile Using a High-Sensitivity Versus a Contemporary.

Figure 1 Flow diagram displaying the proportions of patients with troponin measurements available from all eligible patients and the resulting study population.

Tobias Reichlin, M. D. , Willibald Hochholzer, M. D

Survival probability (%)

Improving Care Processes for Patients with Possible Acute Coronary Syndrome (ICARE-ACS)

HCS 589 Possible Is Everything/tutorialrank.com

HCS 586 Education for Service/tutorialrank.com

Part III Lessons Learned: A Master Class in High-Sensitivity Troponin A Global Perspective.

Optimizing Outcomes in Short Bowel Syndrome With IF

Cardiac Troponin.

Biomarker-Driven Management of Sepsis and Antibiotics Evidence and Perspectives.

The Clinical Enigma of Cardiogenic Shock

Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.

Best Practices in Huntington Disease

Diagnostic Algorithms for ACS and High-Sensitivity Troponin

Hospitalizations in the United States Caused by ACS.

Cardiac Biomarkers.

Hunter Syndrome: Why We Need to Diagnose and Treat Early

Data Collection Learning Objectives

Amyloid Imaging for Alzheimer's Disease in Practice

Identifying Patients Suitable for Discharge After a Single-Presentation High-Sensitivity Troponin Result: A Comparison of Five Established Risk Scores.

Neoadjuvant Therapy in HER2-Positive Breast Cancer

The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.

Improving Surgical Patient Safety

Innovative Insulin Combinations: A New strategy for the Person With T2DM.

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.

Statins and New-Onset Diabetes REAL Updates and Clinical Implications

Expert Perspectives on Hyperkalemia for the Specialist

Part I: A Sensible Approach to Sensitive Troponin

Nat. Rev. Cardiol. doi: /nrcardio

Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.

Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.

Learning Objectives Current Practices in Ruling Out AMI.

Advancing Acute Coronary Syndrome Assessment:

Issues in the Management of Hemophilia: A Best Practice Series

Patient Selection, Pharmacoeconomics, and PCSK9 Inhibitors

Overcoming Clinical Inertia

Optimizing Accuracy of Laboratory Testing: Team-Based Strategies to Reduce Biotin Concerns.

Kevin R. King et al. BTS 2016;1:73-86

Nat. Rev. Cardiol. doi: /nrcardio

Managing HF in Primary Care

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

The Oncology Care Team.

A Multidisciplinary Perspective on the Management of Hypoparathyroidism.

Strengthening Lung Cancer Team Connections to Improve Outcomes With Immunotherapy.

When Good Isn't Good Enough

High-Sensitivity Troponin in Clinical Practice

Point-of-Care vs Laboratory INR Testing to Optimize Anticoagulation Management.

AHF Epidemiology Readmissions Reduction Program.

Evaluating the Science of Cardiogenic Shock

Maximizing Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer.

Early Diagnosis and Management of SSc-ILD

Managing HF in Primary Care

Examining the Role of Pharmacokinetics in Hemophilia

Complex Information Management Using a Framework Supported by ECA Rules in XML Presented By Essam Mansour.

Performance of the Manchester Acute Coronary Syndromes decision rule with high-sensitivity cardiac troponin T (hs-cTnT) as the reference standard for the.

Fresh perspectives ON BASAL Insulins in diabetes care

Best Practices in Building HIV Care Networks

Presentation transcript:

Part II: It Takes a Team— Incorporating High-Sensitivity Troponin Into Clinical Care

Program Goals

First Program in Series Part I—A Sensible Approach to Sensitive Troponin

Potential Challenges of hs-cTn

Strategies for Implementation of hs-cTn

Before Transition to hs-cTn

Role of Multidisciplinary hs-cTn Implementation Team

Protocol for Patient Evaluation

TRAPID-AMI Protocol for Early Rule Out/Rule In of AMI

Postimplementation of hs-cTn

Cardiac Troponin Evolution of Temporal Serial Sampling

Reductions in Morbidity/Mortality After Introduction of Sensitive cTn Assay

5 Key Steps to hs-cTn Implementation

Cardiac Troponin Units of Measure

Cardiac Troponin Assays High Accuracy, Different Precision

Comparison of Rule-Out Strategies for AMI Using hs-cTn

APACE Effect of hs-cTn Introduction

Advantages/Challenges of POC cTn Testing

Advantages/Challenges of hs-cTn Testing

Cardiac Troponins

Summary

Follow-Up Program in Series

Abbreviations